The purpose of the present study was to test the hypothesis that lecithin:cholesterol acyltransferase (LCAT) deficiency would accelerate atherosclerosis development in low density lipoprotein (LDL) receptor (LDLr؊/؊) and apoE (apoE؊/؊) knockout mice. After 16 weeks of atherogenic diet (0.1% cholesterol, 10% calories from palm oil) consumption, LDLr؊/؊ LCAT؊/؊ double knockout mice, compared with LDLr؊/؊ mice, had similar plasma concentrations of free (FC), esterified (EC), and apoB lipoprotein cholesterol, increased plasma concentrations of phospholipid and triglyceride, decreased HDL cholesterol, and 2-fold more aortic FC (142 ؎ 28 versus 61 ؎ 20 mg/g protein) and EC (102 ؎ 27 versus 61 ؎ 27 mg/g). ApoE؊/؊ LCAT؊/؊ mice fed the atherogenic diet, compared with apoE؊/؊ mice, had higher concentrations of plasma FC, EC, apoB lipoprotein cholesterol, and phospholipid, and significantly more aortic FC (149 ؎ 62 versus 109 ؎ 33 mg/g) and EC (101 ؎ 23 versus 69 ؎ 20 mg/g) than did the apoE؊/؊ mice. LCAT deficiency resulted in a 12-fold increase in the ratio of saturated ؉ monounsaturated to polyunsaturated cholesteryl esters in apoB lipoproteins in LDLr؊/؊ mice and a 3-fold increase in the apoE؊/؊ mice compared with their counterparts with active LCAT. We conclude that LCAT deficiency in LDLr؊/؊ and apoE؊/؊ mice fed an atherogenic diet resulted in increased aortic cholesterol deposition, likely due to a reduction in plasma HDL, an increased saturation of cholesteryl esters in apoB lipoproteins and, in the apoE؊/؊ background, an increased plasma concentration of apoB lipoproteins.Lecithin:cholesterol acyltransferase (LCAT, 1 EC 2.3.1.43) is a 65-kilodalton glycoprotein that is responsible for the esterification of cholesterol in plasma lipoproteins (1, 2). LCAT catalyzes a two-step reaction that hydrolyzes the sn-2 fatty acid of phospholipid, followed by a transacylation step that transfers the fatty acid to the 3-hydroxyl group of cholesterol, generating cholesteryl ester and lysolecithin. LCAT is activated by apolipoprotein A-I, which is the major apolipoprotein on HDL particles (3). The LCAT enzyme is important in the process of reverse cholesterol transport, which involves the movement of cholesterol from peripheral tissues back to the liver for excretion and is critical for the maintenance of normal concentration, size, and shape of plasma lipoproteins (1, 4).There are two types of LCAT deficiency in the human population, familial LCAT deficiency (FLD) and fish eye disease (FED). FLD patients are characterized by a complete lack of plasma LCAT activity, corneal opacification, anemia, proteinurea, and kidney dysfunction that can lead to renal failure (5, 6). These patients have decreased plasma total and esterified cholesterol, HDL cholesterol, apoA-I, and apoA-II concentrations and increased plasma concentrations of triglyceride, phospholipid, free cholesterol, and VLDL cholesterol. FED is characterized by a partial LCAT deficiency in which patients have corneal opacification, but no anemia or renal disease. Lipid a...